38.18EUR+0.77%Mkt Cap: 37.05B EURP/E: —Last update: 2026-05-14
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates thro…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)7.94
PEG4.65
P/B1.28
P/S0.82
EV/EBITDA6.83
EV/Revenue1.53
EPS (TTM)-2.19
EPS (Forward)4.75
Cash Flow & Leverage
FCF Yield19.74%
FCF Margin16.17%
Operating CF5.93B EUR
CapEx (TTM)2.49B EUR
Net Debt/EBITDA3.17
Net Debt32.23B EUR
Technical
SMA 5038.97 (-2.0%)
SMA 20034.91 (+9.4%)
Beta0.84
S&P 52W Chg24.23%
Avg Vol (30d)2.41M
Avg Vol (10d)2.37M
Technical Indicators
RSI (14)47.5
MACD-0.5401
MACD Signal-0.5786
MACD Hist.+0.0385
BB Upper41.56 EUR
BB Middle38.56 EUR
BB Lower35.57 EUR
BB Width15.52%
ATR (14)1.357 EUR
Vol Ratio (20d)1.05x
52W Range
22.6057% of range49.78
52W High49.78 EUR
52W Low22.60 EUR
Profitability
Gross Margin58.76%
EBITDA Margin22.45%
Profit Margin-7.94%
Oper. Margin26.32%
ROE-13.95%
ROA-3.46%
Revenue Growth-2.40%
Earnings Growth112.90%
Balance Sheet
Debt/Equity1.40
Current Ratio1.05
Quick Ratio0.69
Book Value/Sh29.36 EUR
Cash/Share6.779 EUR
Dividends
Fwd Div Rate0.1100 EUR
Trail. Div Rate0.1100 EUR
Div. Yield0.29%
5Y Avg Yield2.98%
Payout Ratio163.27%
Ex-Div DateApr 27, 2026
Pay Date—
Ownership
Shares Out.982.42M
Float982.42M
Insiders0.00%
Institutions56.80%
Analyst Consensus
Rating1.9 (Buy)
Target (Mean)48.58 EUR
Target Range25.00 EUR – 60.00 EUR
# Analysts19
Company
Market Cap37.05B EUR
Enterprise Value69.39B EUR
Revenue (TTM)45.24B EUR
Gross Profit26.78B EUR
Net Income (TTM)-3.62B EUR
Revenue/Share46.05 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees87.8K
Last Price38.18 EUR
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—